Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia

Conclusions Improved blood glucose control associated to integrated pump/CGM results in a decreased incidence of diabetes-related complications and improves life expectancy as compared to MDI. Using recommended thresholds from the World Health Organization and previous coverage decisions about health technologies in Colombia, it is a cost-effective alternative to MDI for the treatment of type 1 diabetes in Colombia.
Source: Endocrinologia y Nutricion - Category: Endocrinology Source Type: research